Discover Trusted Doctors
for Your Health Needs

Trusted Professionals Ready to Help You

About Dr. Rikin Kartikbhai Shah

Experience

Arnold Palmer Hospital for Children, Orlando Health

Orlando, FL, United States (2022 – Present)

Director of Pediatric Bone Marrow Transplantation and Cellular Therapy, Haley Center for Children’s Cancer and Blood Disorders

University of Oklahoma Health Science Center

Oklahoma City, OK, United States (2018 – 2022)

Assistant Professor, Department of Pediatrics, Pediatric Hematology/Oncology

University of Oklahoma Health Sciences Center

Oklahoma City, OK, United States(2020 – 2022)

Interim Director of Pediatric Transplantation and Cellular Therapy, College of Medicine

University of Oklahoma Health Sciences Center

Oklahoma City, OK, United States (2020 – 2022)

Associate Director of Pediatric Hematology/Oncology Fellowship Program, Jimmy Everest Section

University of Oklahoma Health Sciences Center

Oklahoma City, OK, United States (2020 – 2022)

Director of Ambulatory Stem Cell Service, Jimmy Everest Section of Pediatric Hematology/Oncology

Education

Smt. N.H.L Municipal Medical College

Ahmedabad, India (2003 – 2009)

Bachelor of Medicine, Bachelor of Surgery

Texas Tech University Health Science Center at Amarillo

Amarillo, TX, United States (2011 – 2014)

Pediatric Resident, Department of Pediatrics

University of Oklahoma Health Science Center

Oklahoma City, OK, United States (2014 – 2017)

Pediatric Hematology/Oncology Fellow, Department of Pediatrics

Baylor College of Medicine

Houston, TX, United States (2017 – 2018)

Pediatric Stem Cell Transplantation Fellow, Department of Pediatric Hematology/Oncology

Research & Publications

Long-Term Organ Function After HCT for SCD: A Report From the Sickle Cell Transplant Advocacy and Research Alliance

Stenger E, Xiang Y, Wetzel M, Gillespie S, Chellapandian D, Shah R, Arnold SD, Bhatia M, Chaudhury S, Eckrich MJ, Kanter J, Kasow KA, Krajewski J, Nickel RS, Ngwube AI, Olson TS, Rangarajan HG, Wobma H, Guilcher GMT, Horan JT, Krishnamurti L, Shenoy S, Abraham A. (2023)

Transplant Cell Ther.

Type 2 innate lymphoid cells from Id1 transgenic mice alleviate skin manifestations of graft-versus-host disease

Srinivasan A, Bajana S, Pankow A, Yuen CH, Shah RK, Sun XH. (2021)

BMC Immunology

IDH1 mutated acute myeloid leukemia in a child with metaphyseal chondromatosis with D-2-hydroxyglutaric aciduriadisease

Srinivasan A, Zhou Y, Scordino TA, Prabhu SG, Wierenga AM, Simon G, Wierenga KJ, Thompson JC, Shah RK, Sinha A. (2020)

Pediatric Hematology and Oncology

Simultaneous B and T cell acute lymphoblastic leukemias in zebrafish driven by transgenic MYC: implications for oncogenesis and lymphopoiesis

Borga C, Park G, Foster C, Burroughs-Garcia J, Marchesin M, Shah RK, Hasan A, Ahmed ST, Bresolin S, Batchelor L, Scordino TA, Miles RR, Te Kronnie G, Regens JL, Frazer JK.(2019)

Leukemia

Encephalocraniocutaneous Lipomatosis

Bavle AA, Shah RK, Gross N, Gavula T, Ruiz-Elizalde AR, Wierenga KJ, McNall-Knapp R. (2018)

Journal of Pediatric Hematology/Oncology

A novel homozygous VPS45 p.P468L mutation leading to severe congenital neutropenia with myelofibrosis

Shah RK, Munson M, Wierenga KJ, Pokala HR, Newburger PE, Crawford DF. (2017)

Pediatric Blood & Cancer

Molecular genetics of childhood, adolescent and young adult non-Hodgkin lymphoma

Miles RR, Shah RK, Frazer JK.(2016)

British Journal of Haematology

N-acetylcysteine renoprotection in methotrexate induced nephrotoxicity and its effects on B-cell lymphoma

Singh R, Shah RK, Turner C, Regueira O, Vasylyeva TL.(2015)

Indian Journal of Medical and Paediatric Oncology

N-acetylcysteine rescue protocol for nephrotoxicity in children caused by ifosfamide

Hanly L, Rieder MJ, Huang SH, Vasylyeva TL, Shah RK, Regueira O, Koren G.

(2013)

Journal of Population Therapeutics and Clinical Pharmacology

childifosfamide

Shah RK, Sethi VK, Bridges WJ, Abiodun JO.(2012)

Open Journal of Pediatrics

Onychomadesis secondary to penicillin allergy in a child

Shah RK, Uddin M, Fatunde OJ. (2012)

The Journal of Pediatrics

Two patients with an anti-N-methyl-D-aspartate receptor antibody syndrome-like presentation and negative results of testing for autoantibodies

Shah RK, Veerapandiyan A, Winchester S, Gallentine W, Mikati MA. (2011)

Pediatric Neurology

Preservation of Pulmonary Function Following Hematopoietic Cell Transplant for Sickle Cell Disease: A STAR Study

Horan F, Bendiak G, Abraham A, Liu K, Gillespie S, Chellapandian D, Shah RK, Bhatia M, Chaudhury S, Eckrich M, Jaroscak J, Kasow K, Krajewski J, Nguwube A, Horan J, Krishnamurti L, Shenoy S, Guilcher G, Stenger E. (2023)

Transplantation and Cellular Therapy

Donor Hemoglobin Genotype Does Not Impact Outcomes Following Matched Related Donor Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Study

Stenger E, John TD, Chellapandian D, Shah RK, Gillespie S, Xiang Y, Liu K, Bhatia M, Guilcher GMT, Jaroscak J, Kasow KA, Krajewski J, Ngwube AI, Rangarajan HG, Horan JT, Krishnamurti L, Shenoy S, Abraham A. (2023)

Blood

Regimen Intensity and Age Affect Transplant-Related Outcomes after Matched Related Donor Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Registry Study

John TD, Chellapandian D, Shah RK, Gillespie S, Liu K, Xiang Y, Bhatia M, Chaudhury S, Eckrich MJ, Guilcher GMT, Jaroscak J, Kasow KA, Krajewski J, Ngwube AI, Olson TS, Rangarajan HG, Horan JT, Krishnamurti L, Shenoy S, Abraham A, Stenger E. (2023)

Blood

Recovery of innate lymphoid cells after allogeneic stem cell transplant: A single institution pilot study

Srinivasan A, Shah RK. (2020)

The Journal of Immunology

Retrospective Review of Use of Individualized Dosing of Rabbit Anti-Thymocyte Globulin on Outcomes in Pediatric Post Allogeneic Stem Cell Transplant Patients

Srinivasan A, Shah RK, Anderson M, Stubblefield A, Admiraal R, Boelens J-J, Crawford DF. (2019)

BBMT

Decreasing the Rate of Asparaginase Reactions due to Hyperammonemia

McNall-Knapp R, Sims K, Shah RK, Mazzone S, Peek L, Howard S. (2017)

Pediatric Blood and Cancer